NGL Fine-Chem Limited (NSE:NGLFINE)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals	5.01B	3.68B	3.39B	2.78B	3.18B
Pharmaceuticals Growth	36.03%	8.73%	21.79%	-12.42%	23.08%
Total	5.01B	3.68B	3.39B	2.78B	3.18B
Total Growth	36.03%	8.73%	21.79%	-12.42%	23.08%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	1.58B	938.73M	792.74M	603.03M	748.58M
India Growth	68.21%	18.42%	31.46%	-19.44%	30.75%
Europe	6.87M	439.36M	704.59M	808.38M	871.59M
Europe Growth	-98.44%	-37.64%	-12.84%	-7.25%	8.03%
Asia Pacific	1.44B	1.13B	980.01M	927.40M	937.69M
Asia Pacific Growth	28.00%	15.15%	5.67%	-1.10%	14.27%
USA	1.50M	47.88M	62.03M	55.08M	98.40M
USA Growth	-96.86%	-22.82%	12.62%	-44.02%	44.43%
Rest of The World	1.91B	1.08B	797.74M	341.86M	472.01M
Rest of The World Growth	77.49%	34.85%	133.36%	-27.58%	67.40%
Total	4.94B	3.63B	3.34B	2.74B	3.13B
Total Growth	36.11%	8.79%	21.98%	-12.55%	22.68%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error